1. "2013"
Formats
  1. Journal Article (2495)
  2. Meeting Abstract (1292)
  3. Book Section (250)
  4. Conference Paper (18)
  5. Book Whole (17)
  6. Review (1)
Groups
  1. Department of Medicine (1421)
  2. GSK Faculty (1000)
  3. Surgery (873)
  4. Solid Tumor Oncology Division (781)
  5. Survivorship Research (671)
  6. Sloan Kettering Institute Faculty (646)

More Groups

People
  1. Jose Baselga (74)
  2. Clifford Hudis (69)
  3. Jedd Wolchok (65)
  4. Howard Scher (62)
  5. Mithat Gonen (62)
  6. Ross Levine (62)

More People

Years
  1. 2013 (4073)
Publications
  1. Journal of Clinical Oncology (366)
  2. Blood (190)
  3. Cancer Research (119)
  4. International Journal of Radiation Oncology, Biology, Physics (88)
  5. Modern Pathology (88)
  6. Laboratory Investigation (81)

More Publications

Publishers
  1. Elsevier Inc. (502)
  2. American Society of Clinical Oncology (386)
  3. Springer (304)
  4. Nature Publishing Group (249)
  5. Elsevier Science, Inc. (206)
  6. American Society of Hematology (192)

More Publishers

Results (4073)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Phase II study of everolimus and sorafenib for the treatment of metastatic thyroid cancer
    Meeting Abstract

    Sherman, E. J.; Ho, A. L.; Fury, M. G.; Baxi, S. S.; Haque, S.; Lipson, B. L.; Kurz, S.; Fagin, J. A.; Pfister, D. G.
    Journal of Clinical Oncology (2013)

    Fulltext@MSK | Save
  • Genome sequencing of multiple primary tumors to reveal underlying germline cancer susceptibility
    Meeting Abstract

    Schrader, K. A.; Stratton, K. L.; Murali, R.; Laitman, Y.; Cavallone, L.; Offit, L.; Wen, Y. H.; Shah, S.; Rau-Murthy, R.; Manschreck, C.; more...
    Journal of Clinical Oncology (2013)

    Fulltext@MSK | Save
  • A phase I study of carboxyamidotriazole orotate (CTO) in of advanced solid tumors
    Meeting Abstract

    Sandler, A.; Taylor, M. H.; Urba, W. J.; Omuro, A. M. P.; Anderson, B. D.; Hansen, D.; Fisher, B.; Claeys, A. J.; Greathouse, A.; McLean, S.; more...
    Journal of Clinical Oncology (2013)

    Fulltext@MSK | Save
  • A phase I dose-escalation and cohort expansion study of lirilumab (anti-KIR; BMS-986015) administered in combination with nivolumab (anti-PD-1; BMS-936558; ONO-4538) in patients (Pts) with advanced refractory solid tumors
    Meeting Abstract

    Sanbom, R. E.; Sharfman, W. H.; Segal, N. H.; Hodi, F. S.; Wolchok, J. D.; Urba, W. J.; Fox, B. A.; Topalian, S. L.; Pardoll, D. M.; Covello, K. L.; more...
    Journal of Clinical Oncology (2013)

    Fulltext@MSK | Save
  • Centralized independent disease status adjudication for maintenance treatment evaluation in advanced ovarian cancer setting: A critical analysis of the MIMOSA trial experience
    Meeting Abstract

    Scartoni, S.; Pfisterer, J.; Sabbatini, P.; Berek, J. S.; Bertolotti, M.; Contini, M.; Cristina, G.; Otranto, I.; Melani, L.; Poggiali, G.; more...
    Journal of Clinical Oncology (2013)

    Fulltext@MSK | Save
  • A pilot study comparing circulation tumor cells (CTC) detection by AdnaTest prostate assay to CellSearch in patients (pts) with castration resistant prostate cancer (CRPC)
    Meeting Abstract

    Samoila, A.; Bastos, D. A.; Herkal, A.; Patel, C.; Curtis, K. R.; Schreiber, N. A.; Anand, A.; Fleisher, M.; Scher, H. I.; Danila, D. C.
    Journal of Clinical Oncology (2013)

    Fulltext@MSK | Save
  • An exploratory analysis of bone scan lesion area (BSLA), circulating tumor cell (CTC) change, pain reduction, and overall survival (OS) in patients (pts) with castration-resistant prostate cancer (CRPC) treated with cabozantinib (cabo): Updated results of a phase II nonrandomized expansion (NRE) cohort
    Meeting Abstract

    Scher, H. I.; Smith, M. R.; Sweeney, C.; Corn, P. G.; Logothetis, C.; Vogelzang, N. J.; Smith, D. C.; Hussain, M.; George, D. J.; De Bono, J. S.; more...
    Journal of Clinical Oncology (2013)

    Fulltext@MSK | Save
  • Prognostic implication of KIT mutations in melanoma
    Meeting Abstract

    Roth, K. G.; Zabor, E. C.; Colgan, M. N.; Wolchok, J. D.; Chapman, P. B.; Schwartz, G. K.; Panageas, K. S.; Carvajal, R. D.
    Journal of Clinical Oncology (2013)

    Fulltext@MSK | Save
  • The Borealis-2 clinical trial: A randomized phase II study of OGX-427 plus docetaxel versus docetaxel alone in relapsed/refractory metastatic urothelial cancer
    Meeting Abstract

    Rosenberg, J. E.; Hahn, N. M.; Regan, M. A.; Jacobs, C.; Stewart, P. S.; Choueiri, T. K.
    Journal of Clinical Oncology (2013)

    Fulltext@MSK | Save
  • Relationship of baseline PSA and degree of PSA decline to radiographic progression-free survival (rPFS) in patients with chemotherapy-naive metastatic castration-resistant prostate cancer (mCRPC): Results from COU-AA-302
    Meeting Abstract

    Ryan, C. J.; Londhe, A.; Molina, A.; Smith, M. R.; De Bono, J. S.; Mulders, P.; Rathkopf, D. E.; Saad, F.; Logothetis, C.; Fizazi, K.; more...
    Journal of Clinical Oncology (2013)

    Fulltext@MSK | Save